非酒精性脂肪性肝病与胆石症的相关性研究进展

黄英; 陈洪

doi:10.3969/j.issn.1001-5256.2014.11.033

非酒精性脂肪性肝病与胆石症的相关性研究进展

DOI: 10.3969/j.issn.1001-5256.2014.11.033

黄英,
陈洪

1. 东南大学第二附属医院内科
2. 东南大学附属中大医院消化科

详细信息

中图分类号: R575.5;R575.62
计量
- 文章访问数: 2531
- HTML全文浏览量: 9
- PDF下载量: 547
- 被引次数: 0
出版历程
- 收稿日期: 2014-07-24
- 出版日期: 2014-11-20

Research progress in association between nonalcoholic fatty liver disease and gallstone disease

Department of Internal Medicine, Affiliated Second Hospital, Southeast University

摘要

摘要: 非酒精性脂肪性肝病(NAFLD)和胆石症(GD)是代谢综合征在肝胆系统中的表现,二者与胰岛素抵抗、肥胖、血脂异常、血糖异常等密切相关。回顾了国内外的研究,发现胰岛素抵抗、肥胖、血脂紊乱、血糖异常、中老年、女性是NAFLD和GD的共同高危因素。NAFLD是GD患病的危险因素,GD与非酒精性脂肪性肝炎和肝纤维化密切相关,GD促进NAFLD的进展。从而认为防治NAFLD可降低GD的发病率,防治GD可减缓NAFLD的进展。
- 脂肪肝 /
- 胆结石 /
- 代谢综合征X /
- 胰岛素抵抗 /
- 综述
Abstract: Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GD) are considered the manifestations of metabolic syndrome in the liver and gallbladder. NAFLD and GD are closely related to insulin resistance (IR) , obesity, dyslipidemia, abnormal glucose metabolism, and so on. Worldwide studies, which have been reviewed, show that both NAFLD and GD have the common risk factors, such as IR, obesity, dyslipidemia, abnormal glucose metabolism, and middle- aged and elderly women. NAFLD is the risk factor for GD. GD, closely related to nonalcoholic steatohepatitis and liver fibrosis, accelerates the progression of NAFLD. Thus, it is considered that the prevention and treatment of NAFLD can reduce the incidence of GD, and the progression of NAFLD can be delayed by the prevention and treatment of GD.
- fatty liver /
- cholelithiasis /
- metabolic syndrome X /
- insulin resistance /
- review

HTML全文

参考文献(47)

[1]FAN JG, FARRELL GC.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol, 2009, 50 (1) :204-210.

[2]de ALWIS NM, DAY CP.Non-alcoholic fatty liver disease:the mist gradually clears[J].J Hepatol, 2008, 48 (Suppl 1) :s104-s112.

[3]HAN TQ, JIANG ZY, ZHANG SD.Pathogenesis of the cholesterol stone formation[J].J Surg Concepts Pract, 2009, 14 (2) :125-127. (in Chinese) 韩天权, 蒋兆彦, 张圣道.胆固醇结石形成机制的基因研究现状与展望[J].外科理论与实践, 2009, 14 (2) :125-127.

[4]RAMOS-DE LA MEDINA A, REMES-TROCHE JM, ROESCH-DIETLEN FB, et al.Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease:is it justified?[J].J Gastrointest Surg, 2008, 12 (12) :2097-2102.

[5]ROESCH-DIETLEN F, PREZ-MORALES A, MELO-SANTISTEBAN G, et al.Frequency and clinical, biochemical and histological characteristics of nonalcoholic fatty liver disease in patients with gallstone disease[J].Cir Cir, 2008, 76 (1) :37-42.

[6]MNDEZ-SNCHEZ N, BERMEJO-MARTNEZ LB, VINˇALS Y, et al.Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects[J].World J Gastroenterol, 2005, 11 (39) :6182-6187.

[7] TARGHER G, DAY CP, BONORA E.Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease[J].N Engl J Med, 2010, 363 (14) :1341-1350.

[8]OLAIYA MT, CHIOU HY, JENG JS, et al.Significantly increased risk of cardiovascular disease among patients with gallstone disease:a population-based cohort study[J].PLoS One, 2013, 8 (10) :e76448.

[9]DAY CP.Pathogenesis of steatohepatitis[J].Best Prac Res Clin Gastroenterol, 2002, 16 (5) :663-678.

[10]TAMURA S, SHIMOMURA I.Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease[J].J Clin Invest, 2005, 115 (5) :1139-1142.

[11]CHANG Y, SUNG E, RYU S, et al.Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men[J].J Korean Med Sci, 2008, 23 (4) :644-650.

[12]BIDDINGER SB, HAAS JT, YU BB, et al.Hepatic insulin resistance directly promotes formation of cholesterol gallstones[J].Nat Med, 2008, 14 (7) :778-782.

[13]GURAYA SY.Reappraisal of the management of cholelithiasis in diabetics[J].Saudi Med J, 2005, 26 (11) :1691-1694.

[14]TSAI CJ, LEITZMANN MF, WILLETT WC, et al.Macronutrients and insulin resistance in cholesterol gallstone disease[J].Am J Gastroenterol, 2008, 103 (11) :2932-2939.

[15]XIE Y, NEWBERRY EP, KENNEDY SM, et al.Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice[J].J Lipid Res, 2009, 50:977-987.

[16]CHATRATH H, VUPPALANCHI R, CHALASANI N.Dyslipidemia in patients with nonalcoholic fatty liver disease[J].Semin Liver Dis, 2012, 32 (1) :22-29.

[17]SPELIOTES EK, MASSARO JM, HOFFMANU U, et al.Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat:the framingham heart study[J].Hepatology, 2010, 51 (6) :1979-1987.

[18]ASSY N, KAITA K, MYMIN D, et al.Fatty infiltration of liver in hyperlipidemic patients[J].Dig Dis Sci, 2000, 45 (10) :1929-1934.

[19]PORTINCASA P, DI CIAULA A, WANG HH, et al.Coordinate regulation of gallbladder motor function in the gut-liver axis[J].Hepatology, 2008, 47 (6) :2112-2126.

[20]WANG DQ, COHEN DE, CAREY MC.Biliary lipids and cholesterol gallstone disease[J].J Lipid Res, 2009, 50 (Suppl) :s406-s411.

[21]LIEW PL, LEE WJ, WANG W, et al.Fatty liver disease:predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity[J].Obesity Surgery, 2008, 18 (7) :847-848.

[22]LORIA P, LONARDO A, LOMBARDINI S, et al.Gallstone disease in nonalcoholic fatty liver:prevalence and associated factors[J].J Gastroenterol Hepatol, 2005, 20 (8) :1176-1184.

[23]YU L, HE XD, WU Q, et al.The risk factor of gallstones[J].Chin J Hepatobiliary Surg, 2011, 17 (9) :711-713. (in Chinese) 于岚, 何小东, 武峤, 等.胆囊结石相关危险因素的探讨[J].中华肝胆外科杂志, 2011, 17 (9) :711-713.

[24]FAN Y, WU SD, FU BB.Effect of intestinal transit on the formation of cholesterol gallstones in hamsters[J].Hepatobiliary Pancreat Dis Int, 2007, 6 (5) :513-515.

[25]WANG HH, WANG DQ.Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine[J].Hepatology, 2005, 42 (4) :894-904.

[26]MACHADO M, MARQUES-VIDAL P, CORTEZ-PINTO H.Hepatic histology in patients undergoing bariatric surgery[J].J Hepatol, 2006, 45 (4) :600-606.

[27] VERNON G, BARANOVA A, YOUNOSSI ZM.Systematic review:the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J].Aliment Pharmacol Ther, 2011, 34 (3) :274–285.

[28]WANLESS IR, LENTZ JS.Fatty liver hepatitis (steatohepatitis) and obesity:an autopsy study with analysis of risk factors[J].Hepatology, 1990, 12 (5) :1106-1110.

[29]MOHAMMAD H, ABO-RYIA, HAMDY S, et al.Predictors of gallstone formation in morbidly obese patients after bariatric surgery:A retrospective observational study[J].Surgical Science, 2014, 5:1-5.

[30]HATZIAGELAKI E, KARAGEORGOPOULOS DE, CHOUNTA A, et al.Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease[J].Exp Diabetes Res, 2012, 2012:351974.

[31]CHEN GY, FAN JG.Advances in epidemiological study of fatty liver disease in China[J].Chin J Pract Intern Med, 2013, 33 (9) :738-741. (in Chinese) 陈光输, 范建高.中国脂肪性肝病流行病学研究进展[J].中国实用内科杂志, 2013, 33 (9) :738-741.

[32]ADAMS LA, WATERS OR, KNUIMAN MW, et al.NAFLD as a risk factor for the development of diabetes and the metabolic syndrome:an eleven-year follow-up study[J].Am J Gastroenterol, 2009, 104 (4) :861-867.

[33]SHIBATA M, KIHARA Y, TAGUCHI M, et al.Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men[J].Diabetes Care, 2007, 30 (11) :2940-2944.

[34]WILLIAMSON RM, PRICE JF, GLANCY S, et al.Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes:the edinburgh type 2 diabetes study[J].Diabetes Care, 2011, 34 (5) :1139-1144.

[35]TOLMAN KG, FONSECA V, TAN MH, et al.Narrative review:hepatobiliary disease in type 2 diabetes mellitus[J].Ann Intern Med, 2004, 141 (12) :946-956.

[36]MAWE G.Nerves and hormones interact to control gallbladder function[J].News Physiol Sci, 1998, 13 (1) :84-90.

[37]MOLLESTON J, WHITE F, TECKMAN J, et al.Obese children with steatohepatitis can develop cirrhosis in childhood[J].Am J Gastroenterol, 2002, 97 (9) :2460-2462.

[38]FAN JG, CHEN L, ZHU J, et al.The epidemiology investigation of the relationship between fatty liver and gallstones disease[J].Clin J Gastroeaterol, 2005, 10 (2) :110-112. (in Chinese) 范建高, 陈兰, 朱军, 等.脂肪肝与胆石症关系的流行病学调查[J].胃肠病学, 2005, 10 (2) :110-112.

[39]PILZ S, MANGGE H, OBERMAYER-PIETSCH B, et al.Visfatin/pre-B-cell colony-enhancing factor:a protein with various suggested functions[J].J Endocrinol Invest, 2007, 30 (2) :138-144.

[40]KONG XS, KONG X, MO HY, et al.The epidemological investigation and analysis of gallstones in different occupations[J].Chin J Epidemiology, 2000, 21 (10) :395. (in Chinese) 孔祥森, 孔鑫, 莫惠英, 等.不同职业人群胆结石流行病学调查分析[J].中华流行病学, 2000, 21 (10) :395.

[41]CHEN LY, QIAO QH, ZHANG SC, et al.Metabolic syndrome and gallstone disease[J].World J Gastroenterol, 2012, 18 (31) :4215-4220.

[42]ZHANG Y, LIU D, MA Q, et al.Factors influencing the prevalence of gallstones in liver cirrhosis[J].J Gastroenterol Hepatol, 2006, 21 (9) :1455-1458.

[43] BELLENTANI S, SACCOCCIO G, MASUTTI F, et al.Prevalence of and risk factors for hepatic steatosis in Northern Italy[J].Ann Intern Med, 2000, 132 (2) :112-117.

[44]IOANNOU GN.Cholelithiasis, cholecystectomy, and liver disease[J].Am J Gastroenterol, 2010, 105 (6) :1364-1373.

[45]JIA YL, FAN DP.The relation between recessive gallstones and liver damage[J].J Cap Med Univ, 2000, 21 (1) :49-50. (in Chinese) 贾玉龙, 范东坡.隐性胆囊结石与肝脏损害的关系[J].首都医科大学学报, 2000, 21 (1) :49-50.

[46]FRACANZANI AL, VALENTI L, RUSSELLO M, et al.Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease[J].PLoS One, 2012, 7 (7) :e41183.

[47]FRACANZANI AL, VALENTI L, BUGIANESI E, et al.Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels:A role for insulin resistance and diabetes[J].Hepatology, 2008, 48 (3) :792-798.

施引文献

资源附件(0)

访问统计